0
     

Report Added
Report already added
Tuberculosis Vaccine Treatment Market - Global Outlook and Forecast 2021-2027

Tuberculosis Vaccine Treatment Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Tuberculosis Vaccine Treatment in global, including the following market information:
Global Tuberculosis Vaccine Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Tuberculosis Vaccine Treatment Market Sales, 2016-2021, 2022-2027, (K Dose)
Global top five Tuberculosis Vaccine Treatment companies in 2020 (%)
The global Tuberculosis Vaccine Treatment market was valued at 74 million in 2020 and is projected to reach US$ 83 million by 2027, at a CAGR of 2.8% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tuberculosis Vaccine Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tuberculosis Vaccine Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Type, 2020 (%)
Immune Vaccine
Therapy Vaccine

Global Tuberculosis Vaccine Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Application, 2020 (%)
Self-Procurement
UNICEF
Other

Global Tuberculosis Vaccine Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tuberculosis Vaccine Treatment revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Tuberculosis Vaccine Treatment revenues share in global market, 2020 (%)
Key companies Tuberculosis Vaccine Treatment sales in global market, 2016-2021 (Estimated), (K Dose)
Key companies Tuberculosis Vaccine Treatment sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
1 Introduction to Research & Analysis Reports
1.1 Tuberculosis Vaccine Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tuberculosis Vaccine Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tuberculosis Vaccine Treatment Overall Market Size
2.1 Global Tuberculosis Vaccine Treatment Market Size: 2021 VS 2027
2.2 Global Tuberculosis Vaccine Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Tuberculosis Vaccine Treatment Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Tuberculosis Vaccine Treatment Players in Global Market
3.2 Top Global Tuberculosis Vaccine Treatment Companies Ranked by Revenue
3.3 Global Tuberculosis Vaccine Treatment Revenue by Companies
3.4 Global Tuberculosis Vaccine Treatment Sales by Companies
3.5 Global Tuberculosis Vaccine Treatment Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tuberculosis Vaccine Treatment Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Tuberculosis Vaccine Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccine Treatment Players in Global Market
3.8.1 List of Global Tier 1 Tuberculosis Vaccine Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Tuberculosis Vaccine Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tuberculosis Vaccine Treatment Market Size Markets, 2021 & 2027
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type - Global Tuberculosis Vaccine Treatment Revenue & Forecasts
4.2.1 By Type - Global Tuberculosis Vaccine Treatment Revenue, 2016-2021
4.2.2 By Type - Global Tuberculosis Vaccine Treatment Revenue, 2022-2027
4.2.3 By Type - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
4.3 By Type - Global Tuberculosis Vaccine Treatment Sales & Forecasts
4.3.1 By Type - Global Tuberculosis Vaccine Treatment Sales, 2016-2021
4.3.2 By Type - Global Tuberculosis Vaccine Treatment Sales, 2022-2027
4.3.3 By Type - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
4.4 By Type - Global Tuberculosis Vaccine Treatment Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tuberculosis Vaccine Treatment Market Size, 2021 & 2027
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Other
5.2 By Application - Global Tuberculosis Vaccine Treatment Revenue & Forecasts
5.2.1 By Application - Global Tuberculosis Vaccine Treatment Revenue, 2016-2021
5.2.2 By Application - Global Tuberculosis Vaccine Treatment Revenue, 2022-2027
5.2.3 By Application - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
5.3 By Application - Global Tuberculosis Vaccine Treatment Sales & Forecasts
5.3.1 By Application - Global Tuberculosis Vaccine Treatment Sales, 2016-2021
5.3.2 By Application - Global Tuberculosis Vaccine Treatment Sales, 2022-2027
5.3.3 By Application - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
5.4 By Application - Global Tuberculosis Vaccine Treatment Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Tuberculosis Vaccine Treatment Market Size, 2021 & 2027
6.2 By Region - Global Tuberculosis Vaccine Treatment Revenue & Forecasts
6.2.1 By Region - Global Tuberculosis Vaccine Treatment Revenue, 2016-2021
6.2.2 By Region - Global Tuberculosis Vaccine Treatment Revenue, 2022-2027
6.2.3 By Region - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
6.3 By Region - Global Tuberculosis Vaccine Treatment Sales & Forecasts
6.3.1 By Region - Global Tuberculosis Vaccine Treatment Sales, 2016-2021
6.3.2 By Region - Global Tuberculosis Vaccine Treatment Sales, 2022-2027
6.3.3 By Region - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Tuberculosis Vaccine Treatment Revenue, 2016-2027
6.4.2 By Country - North America Tuberculosis Vaccine Treatment Sales, 2016-2027
6.4.3 US Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.4.4 Canada Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.4.5 Mexico Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Tuberculosis Vaccine Treatment Revenue, 2016-2027
6.5.2 By Country - Europe Tuberculosis Vaccine Treatment Sales, 2016-2027
6.5.3 Germany Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.4 France Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.5 U.K. Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.6 Italy Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.7 Russia Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.8 Nordic Countries Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.5.9 Benelux Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Tuberculosis Vaccine Treatment Revenue, 2016-2027
6.6.2 By Region - Asia Tuberculosis Vaccine Treatment Sales, 2016-2027
6.6.3 China Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.6.4 Japan Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.6.5 South Korea Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.6.6 Southeast Asia Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.6.7 India Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Tuberculosis Vaccine Treatment Revenue, 2016-2027
6.7.2 By Country - South America Tuberculosis Vaccine Treatment Sales, 2016-2027
6.7.3 Brazil Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.7.4 Argentina Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tuberculosis Vaccine Treatment Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Tuberculosis Vaccine Treatment Sales, 2016-2027
6.8.3 Turkey Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.8.4 Israel Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.8.5 Saudi Arabia Tuberculosis Vaccine Treatment Market Size, 2016-2027
6.8.6 UAE Tuberculosis Vaccine Treatment Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Tuberculosis Vaccine Treatment Major Product Offerings
7.1.4 Merck Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Corporate Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Major Product Offerings
7.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.2.5 Japan BCG Lab Key News
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporate Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Major Product Offerings
7.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.3.5 Serum Institute of India Key News
7.4 AJ Vaccines
7.4.1 AJ Vaccines Corporate Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Major Product Offerings
7.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.4.5 AJ Vaccines Key News
7.5 BioFarma
7.5.1 BioFarma Corporate Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma Tuberculosis Vaccine Treatment Major Product Offerings
7.5.4 BioFarma Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.5.5 BioFarma Key News
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Corporate Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Major Product Offerings
7.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.6.5 GreenSignal Bio Pharma Key News
7.7 China National Biotec
7.7.1 China National Biotec Corporate Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec Tuberculosis Vaccine Treatment Major Product Offerings
7.4.4 China National Biotec Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.7.5 China National Biotec Key News
7.8 Biomed Lublin
7.8.1 Biomed Lublin Corporate Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Major Product Offerings
7.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.8.5 Biomed Lublin Key News
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Corporate Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Major Product Offerings
7.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.9.5 Taj Pharmaceuticals Key News
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Corporate Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Major Product Offerings
7.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.10.5 Ataulpho de Paiva Key News
7.11 IVAC
7.11.1 IVAC Corporate Summary
7.11.2 IVAC Tuberculosis Vaccine Treatment Business Overview
7.11.3 IVAC Tuberculosis Vaccine Treatment Major Product Offerings
7.11.4 IVAC Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.11.5 IVAC Key News
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Corporate Summary
7.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Business Overview
7.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.12.5 Queen Saovabha Mem. Inst Key News
7.13 Microgen
7.13.1 Microgen Corporate Summary
7.13.2 Microgen Tuberculosis Vaccine Treatment Business Overview
7.13.3 Microgen Tuberculosis Vaccine Treatment Major Product Offerings
7.13.4 Microgen Tuberculosis Vaccine Treatment Sales and Revenue in Global (2016-2021)
7.13.5 Microgen Key News
8 Global Tuberculosis Vaccine Treatment Production Capacity, Analysis
8.1 Global Tuberculosis Vaccine Treatment Production Capacity, 2016-2027
8.2 Tuberculosis Vaccine Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Tuberculosis Vaccine Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tuberculosis Vaccine Treatment Supply Chain Analysis
10.1 Tuberculosis Vaccine Treatment Industry Value Chain
10.2 Tuberculosis Vaccine Treatment Upstream Market
10.3 Tuberculosis Vaccine Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tuberculosis Vaccine Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tuberculosis Vaccine Treatment in Global Market
Table 2. Top Tuberculosis Vaccine Treatment Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Tuberculosis Vaccine Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Tuberculosis Vaccine Treatment Revenue Share by Companies, 2016-2021
Table 5. Global Tuberculosis Vaccine Treatment Sales by Companies, (K Dose), 2016-2021
Table 6. Global Tuberculosis Vaccine Treatment Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Tuberculosis Vaccine Treatment Price (2016-2021) & (USD/K Dose)
Table 8. Global Manufacturers Tuberculosis Vaccine Treatment Product Type
Table 9. List of Global Tier 1 Tuberculosis Vaccine Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Vaccine Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2016-2021
Table 15. By Type - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2022-2027
Table 16. By Application – Global Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2016-2021
Table 20. By Application - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2022-2027
Table 21. By Region – Global Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Tuberculosis Vaccine Treatment Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2016-2021
Table 25. By Region - Global Tuberculosis Vaccine Treatment Sales (K Dose), 2022-2027
Table 26. By Country - North America Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Tuberculosis Vaccine Treatment Sales, (K Dose), 2016-2021
Table 29. By Country - North America Tuberculosis Vaccine Treatment Sales, (K Dose), 2022-2027
Table 30. By Country - Europe Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Tuberculosis Vaccine Treatment Sales, (K Dose), 2016-2021
Table 33. By Country - Europe Tuberculosis Vaccine Treatment Sales, (K Dose), 2022-2027
Table 34. By Region - Asia Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Tuberculosis Vaccine Treatment Sales, (K Dose), 2016-2021
Table 37. By Region - Asia Tuberculosis Vaccine Treatment Sales, (K Dose), 2022-2027
Table 38. By Country - South America Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Tuberculosis Vaccine Treatment Sales, (K Dose), 2016-2021
Table 41. By Country - South America Tuberculosis Vaccine Treatment Sales, (K Dose), 2022-2027
Table 42. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Sales, (K Dose), 2016-2021
Table 45. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Sales, (K Dose), 2022-2027
Table 46. Merck Corporate Summary
Table 47. Merck Tuberculosis Vaccine Treatment Product Offerings
Table 48. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 49. Japan BCG Lab Corporate Summary
Table 50. Japan BCG Lab Tuberculosis Vaccine Treatment Product Offerings
Table 51. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 52. Serum Institute of India Corporate Summary
Table 53. Serum Institute of India Tuberculosis Vaccine Treatment Product Offerings
Table 54. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 55. AJ Vaccines Corporate Summary
Table 56. AJ Vaccines Tuberculosis Vaccine Treatment Product Offerings
Table 57. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 58. BioFarma Corporate Summary
Table 59. BioFarma Tuberculosis Vaccine Treatment Product Offerings
Table 60. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 61. GreenSignal Bio Pharma Corporate Summary
Table 62. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offerings
Table 63. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 64. China National Biotec Corporate Summary
Table 65. China National Biotec Tuberculosis Vaccine Treatment Product Offerings
Table 66. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 67. Biomed Lublin Corporate Summary
Table 68. Biomed Lublin Tuberculosis Vaccine Treatment Product Offerings
Table 69. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 70. Taj Pharmaceuticals Corporate Summary
Table 71. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offerings
Table 72. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 73. Ataulpho de Paiva Corporate Summary
Table 74. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offerings
Table 75. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 76. IVAC Corporate Summary
Table 77. IVAC Tuberculosis Vaccine Treatment Product Offerings
Table 78. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 79. Queen Saovabha Mem. Inst Corporate Summary
Table 80. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offerings
Table 81. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 82. Microgen Corporate Summary
Table 83. Microgen Tuberculosis Vaccine Treatment Product Offerings
Table 84. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/K Dose) (2016-2021)
Table 85. Tuberculosis Vaccine Treatment Production Capacity (K Dose) of Key Manufacturers in Global Market, 2019-2021 (K Dose)
Table 86. Global Tuberculosis Vaccine Treatment Capacity Market Share of Key Manufacturers, 2019-2021
Table 87. Global Tuberculosis Vaccine Treatment Production by Region, 2016-2021 (K Dose)
Table 88. Global Tuberculosis Vaccine Treatment Production by Region, 2022-2027 (K Dose)
Table 89. Tuberculosis Vaccine Treatment Market Opportunities & Trends in Global Market
Table 90. Tuberculosis Vaccine Treatment Market Drivers in Global Market
Table 91. Tuberculosis Vaccine Treatment Market Restraints in Global Market
Table 92. Tuberculosis Vaccine Treatment Raw Materials
Table 93. Tuberculosis Vaccine Treatment Raw Materials Suppliers in Global Market
Table 94. Typical Tuberculosis Vaccine Treatment Downstream
Table 95. Tuberculosis Vaccine Treatment Downstream Clients in Global Market
Table 96. Tuberculosis Vaccine Treatment Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Tuberculosis Vaccine Treatment Segment by Type
Figure 2. Tuberculosis Vaccine Treatment Segment by Application
Figure 3. Global Tuberculosis Vaccine Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Vaccine Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Tuberculosis Vaccine Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. Tuberculosis Vaccine Treatment Sales in Global Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Tuberculosis Vaccine Treatment Revenue in 2020
Figure 9. By Type - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 10. By Type - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 11. By Type - Global Tuberculosis Vaccine Treatment Price (USD/K Dose), 2016-2027
Figure 12. By Application - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 13. By Application - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 14. By Application - Global Tuberculosis Vaccine Treatment Price (USD/K Dose), 2016-2027
Figure 15. By Region - Global Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 16. By Region - Global Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 17. By Country - North America Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 18. By Country - North America Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 19. US Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 24. Germany Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. France Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 33. China Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. India Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 39. By Country - South America Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share, 2016-2027
Figure 44. Turkey Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Tuberculosis Vaccine Treatment Revenue, (US$, Mn), 2016-2027
Figure 48. Global Tuberculosis Vaccine Treatment Production Capacity (K Dose), 2016-2027
Figure 49. The Percentage of Production Tuberculosis Vaccine Treatment by Region, 2020 VS 2027
Figure 50. Tuberculosis Vaccine Treatment Industry Value Chain
Figure 51. Marketing Channels

Report Title: Tuberculosis Vaccine Treatment Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW